Anti-topoisomerase I antibody levels as serum markers of skin sclerosis in systemic sclerosis
Author:
Affiliation:
1. Department of Dermatology; Faculty of Medicine; Institute of Medical, Pharmaceutical and Health Sciences; Kanazawa University; Kanazawa; Japan
Publisher
Wiley
Subject
Dermatology,General Medicine
Reference15 articles.
1. Autoantibodies in systemic sclerosis;Steen;s,2005
2. Clinical subsets, skin thickness progression rate, and serum antibody levels in systemic sclerosis patients with anti-topoisomerase I antibody;Perera;Arthritis Rheum,2007
3. Evidence-based guidelines for the use of immunologic tests: anticentromere, Scl-70, and nucleolar antibodies;Reveille;Arthritis Rheum,2003
4. Clinical and prognostic associations based on serum antinuclear antibodies in Japanese patients with systemic sclerosis;Kuwana;Arthritis Rheum,1994
5. Clinical associations of anticentromere antibodies and antibodies to topoisomerase I. A study of 355 patients [see comments];Weiner;Arthritis Rheum,1988
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Autoreactive B cell responses targeting nuclear antigens in systemic sclerosis: Implications for disease pathogenesis;Seminars in Arthritis and Rheumatism;2023-02
2. Functionally Active Antibodies to the Angiotensin II Type 1-Receptor Measured by a Luminometric Bioassay Do Not Correlate With Clinical Manifestations in Systemic Sclerosis: A Comparison With Antibodies to Vascular Receptors and Topoisomerase I Detected by ELISA;Frontiers in Immunology;2021-12-09
3. Association of Anti–Topoisomerase I Antibodies of the IgM Isotype With Disease Progression in Anti–Topoisomerase I–Positive Systemic Sclerosis;Arthritis & Rheumatology;2020-09-29
4. Rituximab therapy is more effective than cyclophosphamide therapy for Japanese patients with anti‐topoisomerase I‐positive systemic sclerosis‐associated interstitial lung disease;The Journal of Dermatology;2019-11
5. Interactions of HLA-DR and Topoisomerase I Epitope Modulated Genetic Risk for Systemic Sclerosis;Scientific Reports;2019-01-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3